Literature DB >> 6875755

Bacteriological analysis of jejunostomy fluid after surgery for extrahepatic biliary atresia.

A Leblanc, N Lambert-Zechovsky, E Bingen, M C Proux, M Odièvre.   

Abstract

Quantitative cultures were made of jejunostomy fluid from 22 children with extrahepatic biliary atresia following hepatoportoenterostomy. Bacterial flora characteristics did not differ in patients with or without cholangitis. With the exception of Streptococcus group D, the most frequently encountered bacterial species with the highest mean concentrations in the jejunostomy fluid, were those mostly responsible for cholangitis (Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa). In 19 of 22 acute episodes, the organism causing cholangitis identified in blood and/or liver was also isolated from jejunostomy fluid. However, quantitative determinations in this fluid did not permit reliable identification of this organism. When the same bacterium caused early relapse, it often persisted in the jejunostomy fluid.

Entities:  

Mesh:

Year:  1983        PMID: 6875755

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

1.  Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes.

Authors:  C Pignata; G Budillon; G Monaco; E Nani; R Cuomo; G Parrilli; F Ciccimarra
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

2.  Bacteria ascend to liver from the bilioenteric conduit after choledochojejunostomy in the cholestatic rat.

Authors:  C S Hsieh; L-T Huang; C C Huang; J J Wu; J H Chuang
Journal:  Pediatr Surg Int       Date:  2003-10-15       Impact factor: 1.827

Review 3.  Biliary tract infections: a guide to drug treatment.

Authors:  J F Westphal; J M Brogard
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

4.  A valved hepatic portoduodenal intestinal conduit for biliary atresia.

Authors:  K Tanaka; I Shirahase; H Utsunomiya; T Katayama; S Uemoto; K Asonuma; Y Inomata; K Ozawa
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.